Stocks making the biggest moves after hours: Amazon, Pinterest, Gilead & more

Finance

In this article

A worker assembles a box for delivery at the Amazon fulfillment center in Baltimore, Maryland, U.S., April 30, 2019.
Clodagh Kilcoyne | Reuters

Check out the companies making headlines Thursday after the bell

Amazon — Amazon shares fell more than 6% in after-hours trading after the company reported its first revenue miss in three years and gave weak third-quarter guidance. For the three months ending Sept. 30, Amazon said it expects to book sales between $106 billion and $112 billion, well below consensus estimates of $119.2 billion.

Skyworks Solutions — The California-based semiconductor company reported fiscal third-quarter earnings per share of $2.15, just ahead of the $2.14 per share anticipated by analysts, according to Refinitiv. Revenues also just managed to top estimates. The company’s stock dropped 5% in the overnight session despite the company’s strong fiscal fourth-quarter guidance.

Gilead Sciences — The biopharmaceutical company saw its equity fall just over 2% even after it leapt to a profit in the second quarter. Gilead said its sales increase 21% thanks to demand for its therapies like Covid-19 treatment remdesivir and its hepatitis C virus products. Its net profit was $1.52 billion for the quarter, compared with a loss of $3.34 billion a year earlier.

T-Mobile — Shares of T-Mobile dipped more than 2% in extended trading after the telecommunication company posted a modest beat on revenues during the second quarter. Sales increased 13% to $19.95 billion compared with the $19.34 billion expected by analysts polled by Refinitiv.

Pinterest — Pinterest shares tanked 16% in extended trading after the social media service reported monthly active user figures below Wall Street’s expectations for its second-quarter earnings. The company also said it expects that third-quarter revenues will grow in the “low-40% range” year over year, below where some analysts had forecast.

Articles You May Like

FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
Why ARK Invest thinks it’s an ‘amazing time’ to invest in cutting-edge tech
Capture The New Tax Breaks On Home Improvements
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
How to make your home hurricane resistant, as scientists predict an ‘extremely active’ storm season

Leave a Reply

Your email address will not be published. Required fields are marked *